Oolong tea extract may fight breast cancer because it stops tumours growing, claim scientists
- The tea stopped growth of common cancer cells in the lab at Saint Louis Uni
- Scientists also said high consumers have a lower risk of breast cancer and death
- More research is needed for its suggestion as a less toxic cancer treatment
Oolong tea extract has 'great potential' in the prevention of breast cancer, scientists believe.
Labvoratory tests showed the Chinese tea, used for centuries for its supposed health benefits, stopped the growth of breast cancer cells
Researchers found the extract hampered the DNA of the cancer cells, inhibiting the growth and progression of tumours.
Green tea showed similar promise, the scientists said. However, black and dark tea had little effect on the cells.
Oolong tea extract has 'great potential' in the prevention of breast cancer, scientists believe after positive study findings
Scientists at St Louis University, Missouri, also analysed the rates of breast cancer and deaths from the disease across China.
Their analysis found regions with high oolong tea consumption had generally lower rates of the disease.
The team now say the tea offers promise as a non-toxic approach to prevent breast cancer, which onein eight women will develop in their lifetime.
Researchers, led by Dr Chunfa Huang,examined the effect of oolong tea extract on six breast cancer cell lines.
Cancer cells lines are used in research, and are cancer cells that keep dividing and growing over time under certain conditions in a laboratory.
The team tested two ER-positive and PR-positive lines, one HER2-positive line, and three triple-negative cell lines.
Green and oolong tea extracts prohibited breast cancer cell growth in all six breast cancer cell lines.
Whereas cells treated with black and dark tea extracts showed no or very weak effect.
The team said:'From our results, oolong tea, much like green tea, plays a role in inhibiting breast cancer cell growth, proliferation and tumor progression.
'Oolong tea, same as green tea, can induce DNA damage and cleavage, play an inhibitory role in breast cancer cell growth, proliferation, and tumorigenesis, and [it has] great potential as a chemopreventive agent against breast cancer.'
Green tea has shown anti-cancer benefits in studies before, but oolong tea has been researched less.
Just two per cent of the world's tea production is oolong tea, compared to about 78 per cent black tea, and 20 per cent green tea, the authors said.
It is mostly produced in China, where people have been using it for its supposed medicinal purposes for a historic period of time.
Therefore, the scientists also looked at 2014 data from the Chinese and Fujian province cancer registry annual report.
They found that the incidence of breast cancer in the Fujian province was 35 per cent lower than the national average.
Those who drank the most oolong tea had a 25 per cent lower incidence compared to the average Fujian, and 50 per cent lower than the national average.
They also appeared to have a lower mortality rate - the death rate of high consumers of oolong tea in Fijian was 68 per cent lower than the national average, according to the findingspublished in the journal Anticancer Research.
Although the results are significant, more research is required, the authors said.
'It is clear that more study is needed,' Dr Huang said. 'The lower incidence and mortality in regions with higher oolong tea consumption indicate that oolong tea has great potential for its anti-cancer properties.'
More than 250,000 women in the US were diagnosed with breast cancer in 2018, and around 41,000 die from the illness each year.
Although survival rates have been improving - doubling in the past 40 years in the UK - the treatment is gruelling.
A Breast Cancer Care survey found that women 26 per cent of women found the end of treatment the hardest part of breast cancer.
Ongoing side effects of treatment such as chemotherapy and radiotherapy can make people feel like they are not moving forward after treatment.
Prevention and early diagnosis is key to improving future health prospects, with screening being offered to all women between the age of 50 and 70 in the UK.